The invention relates to the formulation of pharmaceutical compounds. More particularly, the invention provides stable, pharmaceutically acceptable compositions prepared from boronic acid compounds and methods for preparing the compositions. The invention also provides novel boronate ester compounds. The invention further provides boronic acid anhydride compounds useful in the methods of the invention.

 
Web www.patentalert.com

< DNA fragment directing gene expression predominant in flower organ

< Process for the depletion or removal of endotoxins

> Process for chemically bonding an odor-encapsulating agent to textiles and textiles formed by the process

> Hypochlorite free method for preparation of stable carboxylated carbohydrate products

~ 00286